PWMG
GILD icon

Provence Wealth Management Group’s Gilead Sciences GILD Stock Holding History

Provence Wealth Management Group’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		$267K Sell
3,290
-27
-0.8% -$2.1K 0.14% 134
2023
Q3 		$249K Sell
3,317
-533
-14% -$41K 0.15% 124
2023
Q2 		$297K Buy
3,850
+1,376
+56% +$110K 0.17% 114
2023
Q1 		$205K Buy
+2,474
New +$205K 0.14% 133

Other funds holding GILD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Provence Wealth Management Group's GILD Position: Q4 2023 in Review

Provence Wealth Management Group reduced its Gilead Sciences (GILD) stake by 0.81% in Q4 2023, selling an estimated $2.1K and leaving 3,290 shares worth $267K. The position accounts for 0.14% of the portfolio, ranked #134.

Provence Wealth Management Group first reported a position in GILD in Q1 2023 and has held it in 4 quarters since. The position peaked at $297K in Q2 2023. 1,776 funds tracked by Wall St. Rank hold GILD as of Q4 2023.

  • Provence Wealth Management Group held 3,290 shares of Gilead Sciences worth $267K as of Q4 2023.
  • Provence Wealth Management Group sold 27 Gilead Sciences shares in Q4 2023, an estimated $2.1K.
  • Gilead Sciences made up 0.14% of Provence Wealth Management Group's portfolio in Q4 2023, its #134 holding.
  • Provence Wealth Management Group first reported a position in Gilead Sciences in Q1 2023 and has held it in 4 quarters since.
  • Provence Wealth Management Group's Gilead Sciences position peaked at $297K in Q2 2023.
  • 1,776 funds tracked by Wall St. Rank held Gilead Sciences as of Q4 2023.

Based on Provence Wealth Management Group's 13F filing for Q4 2023, filed 6 Feb 2024.